| Financial Year |
March 31 2023 |
| Monetary Funds |
368,680,544.31 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
86,678,174.37 |
| Accounts Receivable |
210,525,789.83 |
| Advances to Suppliers |
54,412,934.40 |
| Other Receivables |
2,071,790.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
592,107,194.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
7,752,150.00 |
| Other Current Assets |
40,241,582.40 |
| Total Current Assets |
1,362,470,159.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
261,219,225.53 |
| Investment Properties |
-- |
| Fixed Assetes |
664,911,956.83 |
| Under-construction Projects |
520,332,003.36 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
202,310,993.80 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
39,695,233.42 |
| Deferred Income Tax Assets |
5,232,517.16 |
| Other Non-Current Assets |
147,814,742.18 |
| Sub-Total of Non-Current Assets |
2,011,482,893.83 |
| Total Assets |
3,373,953,053.68 |
| Short-Term Loans |
244,232,451.39 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
389,418,958.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,238,488.01 |
| Taxes Payable |
3,273,523.54 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
34,411,500.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,924,714.07 |
| Other Current Liabilities |
127,870.46 |
| Sub-Total of Current Liabilities |
698,651,618.83 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,273,716.32 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
52,869,463.91 |
| Total Liabilities |
751,521,082.74 |
| Paid-In Capital(Or Share Stock) |
471,505,353.00 |
| Capital Surplus |
1,512,393,307.47 |
| Surplus Reserve |
52,935,923.73 |
| LESS:Treasury Stock |
86,561,103.68 |
| Undistributed Profits |
672,158,490.42 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,622,431,970.94 |
| Owner's Equity（Stockholder's Equity） |
2,622,431,970.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,373,953,053.68 |
